S
erum amyloid A (SAA) is a high-density lipoprotein (HDL)-associated apolipoprotein expressed primarily by hepatocytes and macrophages. The Saa superfamily contains 4 members, with only isoforms 1 and 2 being acute-phase reactants. Expression of SAA is induced by proinflammatory cytokines, including interleukin (IL) 6, tumor necrosis factor a, and IL-1b. 1, 2 Chronic expression of SAA is associated with inflammatory diseases such as cardiovascular disease, rheumatoid arthritis, and obesity. [3] [4] [5] Several studies have demonstrated a positive correlation between levels of acutephase proteins, such as C-reactive protein and SAA, and the risk of development of cardiovascular disease and have suggested that C-reactive protein and SAA may be biomarkers for cardiovascular disease. Plasma levels of SAA were prognostic of 3-year coronary events in patients with coronary artery disease. 6, 7 Expression of SAA was increased at the site of plaque rupture in the coronary arteries of patients with acute myocardial infarction compared with the aorta, which was used as the internal negative control, suggesting that SAA may contribute to plaque instability. 8 Studies investigating a subgroup of patients with normal levels of low-density lipoprotein (LDL) found that elevated serum levels of C-reactive protein and SAA were risk factors for patients with LDL levels <130 mg/dL. 6 This suggests that SAA may be a useful marker of cardiovascular disease, particularly for patients who do not demonstrate high cholesterol levels but who are still at risk for future cardiovascular events. Several studies have investigated the role of SAA in atherosclerosis using various mouse models. Plasma levels of SAA are increased in LDL receptor-deficient (Ldlr À/À ) mice fed a high-fat diet (21% fat wt/wt) with or without added cholesterol (0.15% wt/wt) for 5 and 10 weeks compared with those fed a chow diet. 3 Plasma levels of SAA after 5 weeks of Western-type diet (WTD) feeding in Ldlr À/À mice significantly correlated with lesional area of the aortic root after 10 weeks on a WTD, suggesting that systemic SAA levels may be predictive of atherosclerosis development and may participate in lesion development. 3 SAA is present in atherosclerotic lesions at all stages of development in both Ldlr À/À and apolipoprotein E-deficient (ApoE À/À ) mice. 3, [9] [10] [11] The viralvector-mediated hepatic overexpression of human SAA1 in ApoE À/À mice has suggested that SAA may be proatherogenic, 11 although the absence of SAA in ApoE À/À mice had no effect on mature lesion formation, 9 as did the transgenic overexpression of SAA1 in adipocytes. 12 SAA was also shown to induce macrophage cholesterol uptake and expression of the scavenger receptor lectin-like oxidized low-density protein receptor 1 (LOX-1) in vitro via formyl peptide receptor, a known receptor for SAA. 13, 14 It also induces proteoglycan and glycosaminoglycan synthesis in vascular smooth muscle cells in vitro and in the aorta in vivo by upregulating transforming growth factor-b production. 15 In addition, SAA is a chemoattractant for monocytes and neutrophils and induces the expression of other chemokines such as monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein 1a. 16, 17 Incubation of human macrophages with recombinant human SAA upregulates mature IL-1b and cathepsin B production and activation of the NLRP3 inflammasome, 18 which is required for the development of atherosclerosis in mice. 19 Together, these in vitro and in vivo studies suggest that SAA may be proatherogenic. SAA is a secreted apolipoprotein produced primarily by hepatocytes and macrophages and is found in the plasma associated with HDL. Although it has been suggested that SAA may have a proatherogenic role in lesion development, the individual roles of SAA produced by macrophages and hepatocytes in the development of atherosclerosis remain unexplored.
The goal of this study was to examine the effect of the absence of the acute-phase SAA isoforms SAA1 and SAA2 on lesion formation in Ldlr À/À mice, looking at both early and late lesion development, and to further elucidate the role of the individual cellular sources of SAA in atherogenesis. Ldlr À/ À mice have several differences compared with ApoE À/À mice, the most notable being their lipoprotein profiles, with LDL being the major lipoprotein that accumulates in the plasma in the Ldlr À/À mouse model, similar to humans. In addition, macrophages express apoE, which promotes cellular cholesterol efflux. We showed that in the absence of SAA, early lesion development is decreased in the ascending aorta but not in the aortic root or innominate artery, independent of effects on plasma lipids and despite an increase in blood monocyte levels. We also demonstrated a novel role for macrophage-derived SAA in atherogenesis.
Materials and Methods

Materials
All chemicals were purchased from Sigma-Aldrich unless otherwise noted. DMEM and RPMI-1640 media were purchased from Fisher Scientific. All antibodies were purchased from eBioscience except as follows. Anti-CD68 APC (FA-11) was purchased from Biolegend. Goat anti-rabbit antibody (A-4914) was purchased from Sigma-Aldrich (A-4914). Rat anti-mouse MOMA-2 (MCA519G) was purchase from AbD Serotec. Rabbit anti-rat IgG H+L chain AF594 was purchased from Invitrogen.
Primers for Real-Time Polymerase Chain Reaction
All primers were purchased from SA Biosciences, with the exception of HPRT. The HPRT primer sequences were as follows: forward, 5 0 -ACC TCT CGA AGT GTT GGA TA-3 0 , and reverse, 5 0 -CAA CAA CAA ACT TGT CTG GA-3 0 .
Murine Studies
Mice globally deficient in both SAA1 and SAA2 (Saa
) on the C57BL/6 background were generated as described. 9, 20 Ldlr À/À mice, also on the C57BL/6 background, were purchased from Jackson Laboratory (stock number 002207; Bar Harbor, ME) and bred in-house. Saa À/À mice were crossed to Ldlr À/À mice, with the genotype of Saa
mice verified by genomic polymerase chain reaction (PCR) using tail DNA. For all experiments, only female mice were used. Mice were maintained on chow diet no. 2918 (4% fat, 0% cholesterol) from Harlan Teklad until aged 8 weeks, when they were switched to a high-fat, high cholesterol WTD (21% milk fat, 0.2% cholesterol wt/wt; TD.88137 from Harlan Teklad) for 6 or 12 weeks. All mice were housed in a specific pathogen-free facility and used in accordance with National Institutes of Health guidelines and protocols approved by the institutional animal care and use committee at the University of Chicago.
Quantification and Histology of Atherosclerosis
Atherosclerosis was quantified as previously described. 21 Briefly, mice were anesthetized and perfused with PBS for 2 minutes, followed by 4% paraformaldehyde/5% sucrose in PBS for 10 minutes. The heart, aortic arch, and its branching arteries were dissected and soaked in 4% paraformaldehyde/ 5% sucrose overnight at 4°C. The tissue was embedded in optimum cutting temperature compound (Sakura Finetek) and stored at À80°C. Tissue was sectioned into 10-lm cryosections using a Leica cryostat (Leica Microsystems) and stained with Gill's hematoxylin (Fisher Scientific), oil red O, and fast green (Sigma-Aldrich). For the innominate artery, lesion area was quantitated in 4 cryosections located 150 to 450 lm above the point where the innominate artery fuses with aortic arch. For the ascending aorta, 3 cryosections were quantitated from the first 300 lm of the apex of the lesser curvature of the aortic arch. For the aortic root, 3 cryosections were quantitated beginning at the appearance of the valve leaflets and the first coronary artery. For all 3 sites, each of the cryosections quantitated was spaced by 100 lm and the average lesion size was calculated. Adjacent aortic sections were stained with hematoxylin and eosin using Gill's hematoxylin (Fisher Scientific) and eosin. For trichrome staining, tissue was stained using Gomori's trichrome method. 22 All images were acquired on a Leica DM IRB microscope (Leica Microsystems) and analyzed using OpenLab 3.1.5 software (PerkinElmer).
Bone Marrow Transplantation Studies
Bone marrow was isolated from donors aged 8 to 12 weeks by flushing the femurs and tibias with RPMI-1640 media supplemented with 2% FCS, 1% penicillin-streptomycin, and 100 U/mL heparin. Red blood cells were lysed with ACK buffer, the hematopoietic cells were resuspended in sterile PBS, and 5910 6 cells were injected intravenously into recipients aged 8 to 12 weeks. Recipient mice were lethally irradiated using 2 doses of whole-body irradiation (500 rads each) from a cesium 137 source, with the first dose 24 hours prior to injection and the second on the morning of injection. Recipient mice received acidified water containing sulfamethoxazole and trimethoprim 1 week prior to and 2 weeks after injection. Recipient mice were fed a standard chow diet for 8 weeks to allow for reconstitution, after which they were fed a WTD for 6 weeks. The heart and aorta were isolated and analyzed, as described above.
Plasma Lipid and Lipoprotein Levels
Plasma levels of total cholesterol and triglycerides were measured in mice fasted for 3 hours using enzymatic colorimetric kits (Roche Diagnostics). Plasma lipoproteins were separated by fast-performance liquid chromatography using tandem Superose 6 columns (GE Healthcare), as described previously. 23 
Flow Cytometry
Flow cytometry was used to quantify blood monocytes and spleen macrophages. For all samples, cells were counted with a hemocytometer, and Fc receptors were blocked using antiFccRII/III antibody 2.4G2 prior to adding the fluorescenttagged antibodies. For blood monocytes, mice were anesthetized and bled through the retro-orbital sinus. Red blood cells were lysed using red blood cell lysis buffer (eBioscience 
Western Blot Analysis
Plasma from an individual mouse was loaded in each well of a 16% polyacrylamide gel. Proteins were separated using SDS-PAGE, transferred to Immobilon at 4°C using 20% methanol and 1x Tris-glycine. After blocking with 5% milk overnight at 4°C, the blots were probed with a rabbit anti-mouse SAA antibody (1:3000 dilution), as described previously, 24 for 1 hour at room temperature, followed by goat anti-rabbit antibody (1:1000 dilution, A-4914) for 40 minutes at room temperature. Peroxidase enhanced chemiluminescence Western blotting substrate (Thermo Scientific Pierce) was used to visualize bands. The Western blot signal was quantified using FluorChem v2.0 Spot Denso software (ProteinSimple).
Immunofluorescent Staining of the Ascending Aorta
Perfusion-fixed tissues were used for immunofluorescent staining. Ascending aorta cryosections were soaked twice in distilled water for 15 minutes to remove the optimum cutting temperature compound, permeabilized with 0.15% Nonidet P40 substitute for 15 minutes, washed in PBS, and blocked with 10% FCS/PBS for 30 minutes at room temperature. Sections were stained with a 1:100 dilution of rat anti-mouse MOMA-2 (MCA519G) overnight at 4°C. Sections were then stained with a 1:1000 dilution of rabbit anti-rat IgG H+L chain AF594 for 1 hour and DAPI NucBlue Fixed Cell Stain (Invitrogen) for 7 minutes. Images were acquired on a Nikon Eclipse Ti microscope (Nikon Instruments Inc) and analyzed using ImageJ and OpenLab 3.1.5 software (PerkinElmer).
Quantitative Real-Time PCR RNA was isolated from the aortic arch of Ldlr À/À and Saa À/À Ldlr À/À mice fed a WTD for 6 weeks by TRIzol (Invitrogen) extraction, according to the manufacturer's protocol. Next, 1.5 lg of RNA was used to make cDNA using Superscript III (Invitrogen). Gene expression was quantified using real-time PCR with 2 lL of cDNA diluted 1:16 and SYBR green master mix (SA Biosciences, Qiagen). Gene expression was normalized to housekeeping gene HPRT.
Statistical Analysis
Results are presented as mean+SEM. Normality of the data was checked. When normally distributed, the data were analyzed by unpaired Student t test or 1-way ANOVA (for comparisons of ≥3) followed by Tukey's multiple comparison test. When not normally distributed, the data were analyzed by Mann-Whitney U or Kruskal-Wallis test (for comparisons of ≥3) followed by Dunn's post hoc test. All data were analyzed using GraphPad Prism 6 software for Macintosh (GraphPad Software, Inc). Results were considered statistically significant with a P value of <0.05. mice. 9 This modest increase is in contrast to the 100-to 1000-fold increase observed in the acute-phase response, and the fold increase is roughly comparable with the increase in SAA in the plasma of patients with cardiovascular disease compared with healthy controls. 6, 7 Early Atherosclerosis Decreased in the Ascending Aorta of Saa
Results
Plasma
To determine whether the absence of SAA would affect atherosclerosis, cross-sectional analysis was used to examine the ascending aorta, aortic root, and innominate artery in Saa À/À Ldlr À/À and Ldlr À/À mice fed a WTD for 6 or 12 weeks. The absence of SAA resulted in a 31% reduction in lesion size in the ascending aorta after 6 weeks of a WTD but had no effect on lesion size in the innominate artery and the aortic root (Figure 2A ). Histological analysis of the ascending aortic lesions in the mice fed a WTD for 6 weeks ( Figure 3 ) indicated that the lesions were almost completely composed of foam cells staining positive for oil red O, with little to no positive staining for collagen and/or connective tissue, as indicated by trichrome staining. To determine macrophage content, the ascending aorta from mice fed a WTD for 6 weeks was stained for the macrophage marker MOMA-2. In the absence of SAA, there was a reduction in MOMA-2 + lesional area consistent with the reduced atherosclerosis, and no difference was found when normalized to lesion area (percentage of MOMA-2 + /lesional area) ( Figure 4 ).
These data indicated that after 6 weeks of a WTD, lesions were in early stages of development and consisted primarily of macrophage foam cells.
To determine the effect of SAA on more mature lesions, the mice were fed a WTD for 12 weeks; however, no difference in lesion area was observed at any of the 3 arterial sites ( Figure 2B ). The ascending aorta lesions after 12 weeks of WTD were more complex, with an increase in collagen or connective tissue and the presence of a fibrous cap and 
Influence of SAA on Plasma Lipid Levels
To determine whether the moderate increase in SAA expression in the WTD-fed mice influences plasma lipids, cholesterol and triglyceride levels and lipoprotein classes in the plasma were measured. As expected, because SAA levels are barely detectable in chow-fed Ldlr À/À mice, there was no difference in plasma lipids in chow-fed Saa À/À Ldlr À/ À and Ldlr À/À mice ( Figure 6A and 6B). In WTD-fed mice, plasma cholesterol levels were higher in Saa À/À Ldlr À/À mice after 12 weeks of diet ( Figure 6A ), with increased levels of very low density lipoprotein (VLDL) and LDL cholesterol but decreased levels of HDL cholesterol (Figure 6C ). Although plasma triglyceride levels were higher in the WTD-fed Saa À/À Ldlr À/À mice compared with the Ldlr À/ À mice, the difference was not significant ( Figure 6B ). These data suggest that the influence of SAA on atherosclerosis is not dependent on its influence on plasma lipids. included the ascending aorta but not the innominate artery or aortic root. Although a modest reduction in VCAM-1 and MCP-1 expression was found in the absence of SAA, the results were not statistically significant ( Figure 7 ). SAA has also been shown to induce the proinflammatory cytokine IL-23. 27 IL-23 is known to induce production of IL-17A by T-helper 17 cells. It has been shown that IL-17A can promote atherosclerosis in certain contexts. 28 In addition, IL-6 is highly produced by M1 macrophages, inhibits M2 macrophage development, and is known to promote atherogenesis. 29, 30 To determine whether the level of lesional mRNA for these 2 proinflammatory cytokines was higher in the presence rather than in the absence of SAA, real-time PCR was used to quantify mRNA levels in the aortic arch of Ldlr
Gene Expression in the Aortic Arch
and Saa À/À Ldlr À/À mice fed a WTD for 6 weeks. No difference was found in IL-17A and IL-6 mRNA levels ( Figure 7) . 
SAA From Bone Marrow-Derived Cells Participated in the Regulation of Ascending Aorta Atherosclerosis
SAA is a secreted protein primarily produced by hepatocytes and macrophages; however, the roles that each of these sources may play in atherosclerosis is unknown. To examine this, we performed a 4-way bone marrow transplantation study using Saa À/À Ldlr À/À and Ldlr À/À mice as donors and recipients (Table) . Consistent with the studies with the global knockout mice, ascending aorta lesion size was lower in Saa atherosclerosis whether or not SAA was produced by hepatocytes. Consistent with the reduced atherosclerosis in chimeric mice lacking SAA expression in macrophages, there was a decrease in MOMA-2 + lesional area, but no differences were found in the percentage of MOMA-2 + /lesional area ( Figure 8B ), indicating that neither source of SAA affects the relative macrophage content of the ascending aorta lesions. The results from the bone marrow transplantation studies indicated that SAA produced by macrophages had a greater role in enhancing early ascending aorta lesion formation in Ldlr À/À mice than SAA produced by hepatocytes.
A Western blot for SAA was performed on plasma from the bone marrow recipients to assess whether macrophages contributed to plasma SAA levels. SAA was detected in the plasma of the recipient mice when SAA was expressed in hepatocytes (Ldlr but not when SAA was expressed only in bone marrowderived cells (Ldlr À/À ?Saa À/À Ldlr À/À ) ( Figure 8C ). These results indicated that hepatocytes produced the majority of SAA found in the plasma of Ldlr À/À mice fed a WTD, with macrophages contributing little if any plasma SAA. Consequently, the SAA produced locally by bone marrow-derived cells may promote the development of atherosclerosis in the ascending aorta.
Atherosclerosis was Reduced in the Ascending Aorta Despite Increased Levels of Blood Monocytes
Monocytosis in both blood and spleen is associated with an increased risk for the development of atherosclerosis. [31] [32] [33] A possible explanation for the decreased atherosclerosis in the WTD-fed Saa À/À Ldlr À/À mice is that they may have lower blood levels of monocytes. Blood monocytes were quantified using flow cytometry in Saa À/À Ldlr À/À and Ldlr À/À mice fed chow and a WTD for 6 weeks. In the chow-fed animals, there was no difference in blood monocytes (CD45 + CD115 + ) in the presence and absence of SAA expression ( Figure 9B ). Contrary to what was expected, in the absence of SAA in WTD-fed mice, the percentage of total monocytes was increased after 6 weeks on a WTD ( Figure 9C ). Further analysis indicated that it was primarily the Ly6c lo monocyte subset that was elevated. These data are significant because we observed a reduction in atherosclerosis at this time point despite an increase in total blood monocytes, which is often positively associated with atherosclerosis. We did not observe a significant difference in blood monocytes after 12 weeks of WTD, although there was a trend toward increased levels in Saa À/À Ldlr À/À mice ( Figure 9C ).
The reason for the increased blood monocytes in the absence of SAA in the mice fed a WTD for 6 weeks is unclear. We did not observe a significant difference in splenic monocyte (CD45 + F4/80 À CD11b + Ly6c high or low) levels-a potential reservoir of blood monocytes and tissue macrophages-after 6 or 12 weeks on a WTD (data not shown). In addition, we did not observe a difference in blood monocyte proliferation, as determined by cell cycle analysis via flow cytometry, indicating that the absence of SAA does not promote monocytosis by increasing proliferation (data not shown).
To determine which source of SAA might be influencing blood monocyte levels, blood monocytes were quantified using flow cytometry in the bone marrow recipients after 6 weeks of a WTD. Similar to the nonchimeric mice, the percentage of total monocytes was increased only in recipients not expressing SAA in hepatocytes or macrophages (Saa À/À Ldlr À/À ?Saa À/À Ldlr À/À mice) and was primarily due to a higher level of Ly6c lo monocytes ( Figure 9D ).
Interestingly, the data suggest that the difference in Ly6c lo monocytes is due to both hematopoietic and nonhematopoietic factors because recipients that expressed either source of SAA equally prevented an increase in both total and Ly6c lo monocytes compared with recipients totally deficient in SAA.
Further experiments are required to determine how the presence and absence of SAA modulates monocyte homeostasis in Ldlr À/À mice fed a WTD. This issue is under current investigation.
To determine whether the difference in the levels of Ly6c lo monocytes influenced the development of atherosclerosis after 6 weeks of WTD feeding, Pearson's correlation test was performed on both data sets. No correlation was found in either case ( Figure 9E ), suggesting that the influence of SAA on peripheral blood Ly6c lo monocyte levels was independent of its influence on atherogenesis.
Macrophages Were Reduced in the Spleen and Peritoneal Cavity Despite the Elevation of Blood Monocytes
The spleen has been shown to serve as a reservoir for monocytes and macrophages on consumption of a high-fat, high-cholesterol diet that can be recruited to aortic lesions contribute to the growth of atherosclerotic lesions. 32, 34 As mentioned above, there was no difference in the number of monocytes in the spleen as a function of the presence or absence of SAA. We used flow cytometry to determine whether SAA influenced the amount of macrophages (CD45.2 + F4/80 + CD68 + cells) in the spleen and peritoneal fluid of mice fed a WTD for 6 weeks. Spleen and resident peritoneal macrophages were increased in the presence of SAA ( Figure 10A through 10C) . To determine whether SAA expressed by macrophages and/or hepatocytes promoted an increase in splenic macrophages, we also quantified splenic macrophages in the bone marrow recipients. Recipients that did not express SAA in macrophages (Saa À/À Ldlr À/À ?Saa
lower levels of splenic macrophages compared with recipients that expressed SAA in macrophages ( Figure 10D ). These results indicate that SAA produced by macrophages may increase the amount of macrophages in the spleen in WTD-fed mice. 
Discussion
This study is the first report of an examination of the effect of the absence of the acute-phase protein SAA on atherogenesis in the Ldlr À/À background. We identified 3 novel findings related to SAA and atherogenesis and monocyte biology. First, we found that SAA deficiency attenuated atherogenesis in the ascending aorta during early lesion development and did not influence mature lesion formation. This is a site-selective response because these differences were found only in the ascending aorta after 6 weeks of WTD. Second, we showed that this attenuation appeared to be attributable to the /ug protein absence of SAA production by macrophages, as discerned from bone marrow transplantation experiments. Third, we demonstrated that despite there being less atherosclerosis in the absence of SAA, there were higher levels of total blood monocytes.
The absence of SAA in Ldlr À/À mice resulted in a reduction in early lesion formation in the ascending aorta but not in the innominate artery or aortic root after 6 weeks of a WTD. Histological staining of the ascending aorta indicated that lesions after 6 weeks of a WTD were early in development and 
Ldlr
À/À and Ldlr À/À mice were similar in size and more mature in composition. The reason for the site-specific effect of SAA is not clear, but the lack of an effect on aortic root lesions may be related to the fact that this site is the first in mice to develop atherosclerosis, and thus the lesions at this site are more mature even in the mice fed a WTD for 6 weeks. In contrast, the lesions in the innominate artery were very small, yet there was no effect of SAA deficiency. SAA does not appear to influence cholesterol loading of the foam cells because no difference was found in cholesterol uptake by peritoneal macrophages from the 2 strains of mice in vitro with acetylated LDL or in vivo in WTDfed mice or in the expression LOX-1 in the ascending aorta (data not shown). Our results suggest that SAA may influence lesion formation by affecting processes involved in early lesion formation, such as increased expression of adhesion molecules and chemokines involved in leukocyte and monocyte infiltration, although differences in differentiation of monocytes into macrophages or their retention in the aortic tissue 30, [35] [36] [37] [38] may also have a role. Previous in vitro and in vivo studies have found that increased levels of SAA regulate expression of adhesion molecules such as VCAM-1, CD62L (L-selectin), and CD11b and chemokines such as MCP-1 in endothelial cells, leukocytes, and aortic root lesions.
11,16
We observed a trend toward higher expression of VCAM-1 and MCP-1 in the aortic arch in mice expressing SAA. Ly6c 12 weeks on a high-fat diet (16% fat, 0.25% cholesterol). 11 De
Beer et al demonstrated recently that the absence of SAA1 and SAA2 in ApoE À/À mice did not affect lesion formation in the whole aorta or the aortic root in male and female mice fed a chow diet for 50 weeks or a WTD for 12 weeks. 9 Although this may seem to contradict our results, it should be noted that the lesions in the Saa À/À ApoE À/À mice were significantly larger and more advanced than we observed in the Ldlr À/À mice after 6 weeks on a WTD. In our studies, too, no difference in lesion size was observed when larger, more advanced lesions were present. Taken together, these data support the conclusion that SAA influences early lesion formation. Lesion formation was found to be independent of plasma lipid levels because no difference was found in plasma levels of total, VLDL, or LDL cholesterol after 6 weeks of a WTD; however, the absence of SAA seemed to modestly increase plasma triglycerides and HDL cholesterol after 6 weeks of a WTD. This finding is surprising because SAA is mostly an HDLassociated apolipoprotein, and SAA's dramatic increase during the acute-phase response is associated with a significant reduction in HDL and apoA-I. 39 Nonetheless, the SAA levels induced by the WTD feeding were upregulated 4-fold, whereas during the acute-phase response, SAA levels were upregulated 100-to 1000-fold compared with a noninflammatory state. In contrast, after 12 weeks of a WTD, VLDL and LDL levels were increased and HDL was decreased in the Saa À/À Ldlr À/À mice. This is a proatherogenic lipid profile and could have contributed to the accelerated lesion growth in the ascending aorta of the Saa À/À Ldlr À/À mice so that, at this time, there is no difference between the lesions sizes of the 2 strains. Using bone marrow chimeras, we also showed that SAA produced by macrophages was more likely to promote lesion formation in the ascending aorta and an increase in lesional and splenic macrophages. These observations are noteworthy, given that hepatocytes produce the majority of SAA that is present in the plasma, with macrophages contributing little if any plasma SAA. These results suggest that SAA may have local effects on lesional macrophages prior to or after secretion or effects on other cells in the vessel wall that may influence lesion formation. Consistent with the role of macrophage-derived SAA, the transgenic mediated overexpression of human SAA1 in adipocytes also does not influence the development of atherosclerosis in chow-fed ApoE À/À mice. 12 There is an emerging consensus that monocytosis is a risk factor for the development of atherosclerosis in a variety of models and in humans. In most cases, this involves the elevation of Ly6c hi proinflammatory monocytes. 33, 40 These monocytes enter the intima, where they differentiate into macrophages expressing CCR2, the receptor for MCP-1, and promote lesion development in atherosclerosis-susceptible sites. 31, 41 We reported a decrease in atherosclerosis despite an increase in total monocytes in the blood of Saa À/À Ldlr À/À mice. In this case, the monocytes were predominantly Ly6c lo monocytes that are thought to patrol the vascular endothelium. 38 Ly6c lo monocytes do not express CCR2 and generally are thought to develop into alternatively activated and antiatherogenic M2 macrophages that have been suggested to promote tissue remodeling and the resolution of atherogenesis. 42 Consequently, this increment of Ly6c lo polarized monocytes should not be taken to contradict the emerging consensus. The increase in Ly6c lo monocytes could well contribute to the reduced atherosclerosis observed in the absence of SAA expression. Although a higher level of Ly6c lo monocytes and a reduction of atherosclerosis were both found in the absence of SAA after 6 weeks of a WTD, no correlation was found between these 2 observations by Pearson's correlation coefficient analysis. It is quite possible that these 2 phenomena were induced simultaneously by a hyperlipidemic state but regulated by separate mechanisms. The way in which SAA influences the polarity of blood monocytes has yet to be established. We did not observe an effect of SAA expression on the proliferation of blood monocytes, as determined by cell cycle analysis (data not shown), indicating that SAA does not influence monocyte proliferation. A possibility is that SAA influences expression of factors involved in monocyte subset differentiation or survival, such as nuclear orphan receptor NRA41. 43 In conclusion, we showed that SAA produced by macrophages increased the amount of lesional macrophages, promoting early lesion development. It is clear from this study and others that the role of SAA in atherosclerosis is dependent on several factors including the genetic background of the different models used for study, lesion site and size, and the duration of an experiment. Further studies are needed to further clarify how SAA may influence lesion development and blood and tissue monocyte and macrophage homeostasis.
